abstract |
A method to treat conditions associated with Abeta peptide activity both prophylactically and therapeutically is described. The method employs humanized antibody fragments that specifically bind human Abeta peptide between amino acid positions 13-28, wherein the antibody fragments are covalently attached to a polyethylene glycol (PEG) molecule. |